National Sleep Day, which falls on March 17th, is an opportunity to highlight that nearly 60% of cancer patients suffer from insomnia during and after treatment. Non-pharmacological solutions exist for treating this disorder.

Gustave Roussy is launching Orakl, start-up aiming to improve and accelerate pharmaceutical research in oncology

back to job offer list

back to clinical trials

Villejuif, 14th march 2023

Emerging Clonal Interception Program

back to job offer list

back to clinical trials

A pioneering scientific program to anticipate the risk of leukemia induced by previous anticancer treatments.

Project leader: Jean-Baptiste Micol

Clémence Nguyen-Vigouroux, chercheuse

back to job offer list

back to clinical trials

Clémence Nguyen-Vigouroux,
chercheuse

" Si vous êtes passionnée, foncez ! "

Sophie Postel-Vinay, femme de sciences, l’innovation thérapeutique à cœur

back to job offer list

back to clinical trials

Dr Sophie Postel-Vinay,
femme de science, l’innovation thérapeutique à cœur

Emerging Epigenetics Program

back to job offer list

back to clinical trials

A pioneering scientific program to better understand the epigenetic biology of tumors and find new treatments.

Project leader: Sophie Postel-Vinay

Jean-Baptiste Micol

back to job offer list

back to clinical trials

Dr. Jean-Baptiste Micol

Jean-Baptiste Micol

Jean-Luc Perfettini

Insomnia: a major public health issue

Clémence Nguyen-Vigouroux,chercheuse

Dr Sophie Postel-Vinay,femme de science, l’innovation thérapeutique à cœur

Dr. Jean-Baptiste Micol

Pages

Clémence Nguyen-Vigouroux,
chercheuse

Dr Sophie Postel-Vinay,
femme de science, l’innovation thérapeutique à cœur